- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Prostatic Neoplasms
Medical specialists from France tagged as investigators in clinical trials studying Prostatic Neoplasms
Total 332 results
-
Jean-Briac PrevostSeen in:
- Beuvry, Centre de Radiotherapie Pierre Curie
- Beuvry, Groupe Radiopole Artois - Centre de Radiotherapie Pierre Curie
Trials:- NCT02799706 (Principal Investigator)
- NCT05512364 (Principal Investigator)
- NCT02834884 (Principal Investigator)
-
Jean-François Ntoutoume, MDSeen in:
- Picardie, Amiens, Centre Hospitalier Universitaire d'Amiens
Trials:- NCT06094322 (Sub-Investigator)
Conditions: -
Jean-Georges GUERIN WALLNER, MDSeen in:
- Caen, Polyclinique du Parc
Trials:- NCT04638088 (Principal Investigator)
Conditions: -
Jean-Luc DESCOTES, MDSeen in:
- Grenoble, CHU Grenoble - Urologie
Trials:- NCT05739565 (Principal Investigator)
Conditions: -
Jean-Marc SimonSeen in:
- Paris, Assistance Publique - Hopitaux de Paris - La Pitie Salpetriere
Trials:- NCT02799706 (Principal Investigator)
Conditions: -
Jean-Michel CORREAS, MD, PhDSeen in:
- Paris, Assistance Publique Hôpitaux de Paris - Hôpital Necker - Service de Radiologie adultes
Trials:- NCT02295449 (Principal Investigator)
Conditions: -
Jérôme Martin-Babau, MDSeen in:
- Plerin, Centre CARIO-Hôpital Privé des Côtes d'Armor (HPCA)
- Plérin, Centre Arrmoricain d'Oncologie
- Plérin, Hopital Privé des Cotes d'Armor
- Plérin, Hôpitla privé des Côtes d'Armor - Centre CARIO-HPCA
Trials:- NCT05254639 (Principal Investigator)
- NCT05615818 (Principal Investigator)
- NCT05955170 (Principal Investigator)
- NCT05983367 (Principal Investigator)
- NCT06027632 (Principal Investigator)
- NCT06379880 (Principal Investigator)
-
Jérôme RIgaudSeen in:
- Nantes, CHU Hotel Dieu
Trials:- NCT03088124 (Principal Investigator)
Conditions: -
Jochen WALZSeen in:
- Bouches Du Rhone, Marseille, Institut Paoli Calmettes
- Lyon, Centre Léon Bérard
- Marseille, Department of Radiology and Urology, Institut Paoli-Calmettes Marseille
- Marseille, Institute Paoli-Calmettes
Trials:- NCT04632251 (Principal Investigator)
- NCT03679819 (Principal Investigator)
- NCT04732156 (Sub-Investigator)
- NCT04299646 (Sub-Investigator)
Conditions: -
Jonathan BAZARD, MDSeen in:
- Privas, Activité Physique Adaptée - CDOS Ardèche
Trials:- NCT05739565 (Principal Investigator)
Conditions: -
Joris MARTIN, MDSeen in:
- Clermont-Ferrand, Activité Physique Adaptée - DAHLIR 63
Trials:- NCT05739565 (Principal Investigator)
Conditions: -
Julie COMMERÇON, MDSeen in:
- Lyon, Activité Physique Adaptée - DAHLIR 69
Trials:- NCT05739565 (Principal Investigator)
Conditions: -
Julie Julie, MDSeen in:
- Lyon, Activité Physique Adaptée - DAHLIR 69
Trials:- NCT05739565 (Principal Investigator)
Conditions: -
Julie MALLOIZEL DELAUNAYSeen in:
- Toulouse, Chu Toulouse
Trials:- NCT03580109 (Principal Investigator)
Conditions: -
Julien Langrand-Escure, MDSeen in:
- Saint-Priest-en-Jarez, Institut de Cancérologie Lucien Neuwirth
Trials:- NCT03830788 (Principal Investigator)
Conditions: -
Julien PINOTSeen in:
- Clermont-Ferrand, CHU Clermont-Ferrand - ONCOLOGIE
Trials:- NCT05739565 (Sub-Investigator)
Conditions: -
Karim Fizazi, MDSeen in:
- Val De Marne, Villejuif, Gustave Roussy
Trials:- NCT05551117 (Principal Investigator)
Conditions:- Melanoma;
- Non-small Cell Lung Cancer;
- Small-cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Anal Cancer;
- Malignant Melanoma;
- Non-small Cell Carcinoma;
- Oral Squamous Cell Carcinoma;
- Small Cell Carcinoma;
- Laryngeal Squamous Cell Carcinoma;
- Carcinoma, Squamous Cell of Head and Neck;
- Castration-Resistant Prostatic Cancer;
- Androgen-Independent Prostatic Cancer;
- Androgen-Insensitive Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Anal Neoplasm
-
Kiêù LÊSeen in:
- Le Puy-en-Velay, Centre Hospitalier Emile ROUX
Trials:- NCT04181203 (Principal Investigator)
Conditions: -
Laurene GAVOILLE, MDSeen in:
- Nancy, Centre d'Oncologie de Gentilly
Trials:- NCT06379880 (Principal Investigator)
Conditions: -
Laurent Chauveinc, MDSeen in:
- Levallois-Perret, Centre de Cobalthérapie Hartman
Trials:- NCT03830788 (Principal Investigator)
Conditions: -
Laurent Doucet, PHSeen in:
- Brest, CHRU de Brest
Trials:- NCT04745871 (Sub-Investigator)
Conditions: -
Laurent GUY, MDSeen in:
- Clermont-Ferrand, CHU Clermont-Ferrand - Urologie
Trials:- NCT05739565 (Principal Investigator)
Conditions: -
Laurent Votron, MDSeen in:
- Albi, Clinique Claude Bernard
Trials:- NCT03830788 (Principal Investigator)
- NCT04299646 (Principal Investigator)
Conditions: -
Lauriane EberstSeen in:
- Strasbourg, Strasbourg Europe Institut of Cancerology
Trials:- NCT04104776 (Principal Investigator)
-
Leila BENGRINE, MDSeen in:
- Dijon, Centre Georges François Leclerc
- Dijon, Centre geroges François Leclerc
Trials:- NCT03828227 (Principal Investigator)
- NCT04166604 (Principal Investigator)
- NCT06379880 (Principal Investigator)
-
Lionel BADET, MDSeen in:
- Lyon, Hôpital Hédouard Herriot
Trials:- NCT03572621 (Sub-Investigator)
Conditions: -
Lionel VINCENT, MDSeen in:
- Roanne, CH Roanne
Trials:- NCT05739565 (Principal Investigator)
Conditions: -
Lise WILLEMS, MDSeen in:
- Paris, Hôpital Cochin
- Paris, Hôpital Cochin APHP
Trials:- NCT04446962 (Principal Investigator)
- NCT02649790 (Principal Investigator)
Conditions:- Lymphoma, Large B-Cell, Diffuse;
- Central Nervous System Neoplasms, Primary;
- Acute Myeloid Leukemia (AML);
- Metastatic Colorectal Cancer (mCRC);
- Metastatic Castration-Resistant Prostate Cancer (mCRPC);
- Relapsed/Refractory Multiple Myeloma (RRMM);
- Higher-Risk Myelodysplastic Syndrome (HR-MDS);
- Newly Diagnosed Intermediate/High-Risk MDS
-
Loic MoureySeen in:
- Toulouse, Institut Univ du Cancer de Toulouse-Oncopole
Trials:- NCT04691804 (Principal Investigator)
Clinical Trials on Prostatic Neoplasms
-
Australian and New Zealand Urogenital and Prostate...Peter MacCallum Cancer Centre, AustraliaRecruitingCastration Resistant Prostatic CancerAustralia
-
British Columbia Cancer AgencySanofi; Ozmosis Research Inc.UnknownMetastatic Castration-Resistant Prostatic CancerCanada, Australia
-
Yinghao SunNot yet recruitingCastration-Resistant Prostatic Cancer
-
Institut Claudius RegaudWithdrawnProstatic Cancer, Castration-ResistantFrance
-
Technische Universität DresdenRecruitingOligometastatic Disease | Prostatic Cancer, Castration-ResistantGermany
-
Rio de Janeiro State UniversityCompletedProstatic Cancer | Prostatic NeoplasmBrazil
-
Janssen Research & Development, LLCCompletedCastration-Resistant Prostatic NeoplasmsCanada, Belgium, United States, Spain, Netherlands, Italy, Russian Federation
-
Universität des SaarlandesRecruitingProstate Cancer Metastatic | Advanced Prostate Carcinoma | Castration Resistant Prostatic CancerGermany
-
University Hospital, GrenobleTerminatedCastration-resistant Prostate CancerFrance
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingProstatic Neoplasms, Castration-Resistant | Prostatic Cancer, Castration-Resistant | Castration Resistant Prostatic Neoplasms | Androgen-Resistant Prostatic NeoplasmsUnited States, Canada